The landscape of global
healthcare innovation continues to evolve, led by visionary minds redefining modern medicine through science and technology. Among these thought leaders stands Dr. Adedapo Adesokan, a distinguished Physician-Scientist from the United Kingdom, whose groundbreaking contributions to pharmacology and medical device development are transforming the treatment of unmet clinical needs. As the Director of PreciseMed, Dr. Adesokan’s mission centers on developing novel, patient-focused therapeutic solutions that bridge the gap between discovery and accessibility.
Affiliation: Physician-Scientist working on novel innovative solutions to unmet clinical needs
Organization: Director, PreciseMed
Country: United Kingdom
Dr. Adedapo Adesokan brings a multidisciplinary approach to modern medicine, integrating clinical research, pharmacological innovation, and translational science. His work emphasizes conceptualization and discovery of novel therapies, including over-the-counter medicines, repurposed synthetic drugs, medical devices, and combination products — each designed to address pressing clinical challenges. From preclinical development to FDA licensing, his work exemplifies excellence across the full spectrum of therapeutic innovation.
will be joining us as an esteemed speaker at the 17th Global Digital Pharma, Clinical Trials & Drug Delivery Conference, taking place from December 17–19, 2025, at Novotel Al Barsha, Dubai, UAE.
------------------------------------------------------------------------------------------------
Participants attending Dr. Adesokan’s session at the 17th Global Digital Pharma, Clinical Trials & Drug Delivery Conference 2025 will gain:
Insightful strategies for translating scientific discovery into real-world healthcare solutions.
Inspiration from his journey in developing innovative medical products for complex unmet needs.
Knowledge about the latest approaches to repurposed drug development and clinical validation.
Practical guidance on navigating regulatory frameworks, FDA licensing, and intellectual property pathways.
Networking opportunities with leading pharmaceutical innovators, researchers, and clinicians shaping the future of medicine.
----------------------------------------------------------------------------------------------------------
Submit Your Abstract: https://pharmacy.utilitarianconferences.com/submit-abstract
Register Now to Attend: https://pharmacy.utilitarianconferences.com/registration
--------------------------------------------------------------------------------------------------------
Bibliography & Research Interests
Dr. Adedapo’s special interests lie in the conceptua lisation and discovery of novel therapies — including over-the-counter formulations, repurposed synthetic medicines, medical devices, and combination products. His goal is to translate early-stage discoveries into clinically validated therapies that can make a tangible impact on patients’ lives.
With a focus on unmet clinical needs, Dr. Adedapo’s research integrates pharmacology, biotechnology, and translational medicine — offering a holistic model for 21st-century drug discovery and healthcare innovation.
-----------------------------------------------------------------------------------------------
Work Experience
CEO, PreciseMed Limited (February 2017 – Present)
Under his leadership, PreciseMed has become a hub for scientific innovation and clinical research, dedicated to developing advanced solutions in pharmacology and medical devices. His work combines rigorous research methodologies with a patient-centric approach to improve healthcare delivery and outcomes globally.
-------------------------------------------------------------------------------------------------
Publications & Conference Presentations
Dr. Adedapo has contributed extensively to global scientific knowledge through:
18+ peer-reviewed publications on novel medicines and medical device discoveries.
Numerous abstract presentations at international pharmacology conferences.
Delivered a Keynote Lecture at the World Pharmacology Conference in Glasgow (2024), sharing his insights on translational medicine and innovation in clinical pharmacology.
Patents Filed
Oral Dementia Support Oral Thin Film Strip – First-in-human dementia support probiotics.
Ultra-Fast Relief Flu/COVID Over-the-Counter Therapy – A groundbreaking advancement in rapid relief therapeutics.
These patents exemplify Dr. Adedapo’s commitment to practical innovation — creating accessible, effective treatments that improve quality of life.
-----------------------------------------------------------------------------------------------
Awards & Recognitions
🏅 2010 Student/Trainee Award, American College of Clinical Pharmacology
🏅 2010 Roberts Scientific Networking Award, University of Glasgow
🏅 Young Professional Fellow, Europe Drug Information Association, February 2011
🏆 Winner, 2025 Most Innovative Brit in Healthcare Sector, Innovation & Excellence Award, August 2025
Each recognition highlights Dr. Adedapo’s sustained impact on clinical pharmacology, innovation, and healthcare excellence.
-----------------------------------------------------------------------------------------------------
Registration Link:
Register Now to Attend the Conference: https://pharmacy.utilitarianconferences.com/registration
Event Date: December 17–19, 2025
Location: Dubai, UAE & Virtual
----------------------------------------------------------------------------------------------------
Conclusion
Dr. Adedapo Adesokan stands as a beacon of innovation, vision, and excellence in global healthcare. His pioneering efforts at the intersection of medicine, science, and technology continue to shape the future of pharmacology and therapeutic discovery. Attending his session will provide unparalleled inspiration and practical wisdom for anyone committed to advancing patient-centered innovation in the pharmaceutical and healthcare industries.
---------------------------------------------------------------------------------------------------
Some hashtags
#PharmaInnovation #ClinicalTrials #DrugDiscovery #Pharmacology #HealthcareInnovation #MedicalDevices #OTCMedicines #FDAApproval #GlobalPharmaConference #DigitalPharma2025 #AdedapoAdesokan #PreciseMed #PharmaLeadership #DrugRepurposing #PharmaResearch #ConferenceRegistration #DubaiConference